B-CONVINCED: Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode by Guillaume Jondeau, Yannick Neuder, Jean-Christophe Eicher, Patrick Jourdain, Elodie Fauveau, Michel Galinier, Arnaud Jegou, Fabrice Bauer, Jean Noel Trochu, Anissa Bouzamondo, Marie-Laure Tanguy, and Philippe Lechat EHJ Volume ():ehp323 August 30, 2009 Published on behalf of the European Society of Cardiology. All rights reserved. © The Author For permissions please
Evolution of heart rate (top) and systolic and diastolic blood pressure (bottom) in the two groups. Guillaume Jondeau et al. Eur Heart J 2009;eurheartj.ehp323 Published on behalf of the European Society of Cardiology. All rights reserved. © The Author For permissions please
Percentage of patients improved for both general well-being and dyspnoea according to the fact that they keep (green) or stop (red) beta-blocker therapy, evaluated by a blinded investigator (investigator) or the patient (patient), at Day 3 and at Day 8. Guillaume Jondeau et al. Eur Heart J 2009;eurheartj.ehp323 Published on behalf of the European Society of Cardiology. All rights reserved. © The Author For permissions please